Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUT017 Gel for Cutaneous Wound Healing in Healthy Volunteers
NCT07463378Phase 1Not yet recruiting
- Sponsor
- Antoni Ribas
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of LUT-017 in acute skin wound (3 arms), sponsored by Antoni Ribas. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 7 days. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
LUT-017
03
Conditions
acute skin wound
Beyond the preview
Go deeper on NCT07463378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07463378.